文献速递口腔修复与种植

钛种植体表面性质促进去卵巢骨质疏松大鼠骨结合

Titanium implant surface properties enhance osseointegration in ovariectomy induced osteoporotic rats without pharmacologic intervention.
PubMed 文献 · Clin Oral Implants Res · 2020-01-31

本研究在去卵巢骨质疏松大鼠中比较三种钛种植体表面性质对骨结合的影响,发现微结构/纳米结构/亲水表面种植体在无药物干预下骨结合程度更高,体外成骨细胞标志物产生也增加。结果提示微结构存在时亲水性比纳米结构对骨结合影响更大。

要点

  • 微结构/纳米结构/亲水钛种植体在骨质疏松大鼠中骨结合程度更高
  • 亲水性对骨结合的影响大于纳米结构(存在微结构时)
  • 改性种植体表面可在无药物干预下促进骨质疏松动物的功能性骨结合

核心结论

  • 所有改性钛种植体均可在去卵巢诱导的骨质疏松大鼠中实现骨结合,无需药物干预。
  • 微结构/纳米结构/亲水表面的骨结合程度高于微结构/非纳米结构/疏水及微结构/纳米结构/疏水表面。
  • 当存在适当微结构时,亲水性对钛种植体骨结合的影响大于纳米结构。

研究设计与样本

  • 研究纳入25只8月龄处女雌性CD Sprague Dawley大鼠,行卵巢切除术。
  • 术后6周,每只大鼠股骨远端干骺端植入三种表面特性的钛种植体(Ø2.5 × 3.5 mm)。
  • 植入28天后,采用microCT、组织形态计量学和移除扭矩值评估骨质量与种植体骨结合。
  • 体外分离颅骨成骨细胞,在Ø15 mm钛盘上培养7天,检测骨钙素、骨保护素、骨桥蛋白、BMP2、VEGF和RANKL产生。

主要发现

  • 微结构/纳米结构/亲水种植体在体内促进骨-种植体接触和移除扭矩值增加。
  • 微结构/纳米结构/亲水种植体在体外增加成骨细胞标志物产生。
  • 与微结构/非纳米结构/疏水及微结构/纳米结构/疏水种植体相比,微结构/纳米结构/亲水种植体的骨结合程度更高。

关键数值与推荐

  • 微结构/纳米结构/亲水种植体:体内骨-种植体接触和移除扭矩值增加,体外成骨细胞标志物产生增加(与另两种表面相比)。
  • 微结构/非纳米结构/疏水种植体:作为对照表面之一。
  • 微结构/纳米结构/疏水种植体:作为对照表面之一。

临床怎么用

  • 在骨质疏松患者中,选择具有微结构和亲水性的钛种植体可能改善骨结合。
  • 改性种植体表面可在无药物干预下促进骨质疏松动物的功能性骨结合,为临床种植体选择提供参考。

局限性

  • 研究为动物实验(去卵巢大鼠),结果需在临床研究中验证。
  • 样本量有限(N=25),需更大规模研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study determined whether implant surfaces that promote osseointegration in normal rats can promote osseointegration in osteoporotic rats without pharmacologic intervention. MATERIALS AND METHODS: Virgin female 8-month-old CD Sprague Dawley rats (N = 25) were ovariectomized. At 6 weeks, microstructured/non-nanostructured/hydrophobic, microstructured/nanostructured/hydrophobic, or microstructured/nanostructured/hydrophilic Ti implants (Ø2.5 × 3.5 mm; Institut Straumann AG, Basel, Switzerland) were placed in the distal metaphysis of each femur. At 28 days, bone quality and implant osseointegration were assessed using microCT, histomorphometrics, and removal torque values (RTVs). Calvarial osteoblasts were isolated and cultured for 7 days on Ø15 mm Ti disks processed to exhibit similar surface characteristics as the implants used for the in vivo studies. The phenotype was assessed by measuring the production of osteocalcin, osteoprotegerin, osteopontin, BMP2, VEGF, and RANKL. RESULTS: Microstructured/nanostructured/hydrophilic implants promoted increased bone-to-implant contact and RTVs in vivo and increased osteoblastic marker production in vitro compared to microstructured/non-nanostructured/hydrophobic and microstructured/nanostructured/hydrophobic implants, suggesting that osseointegration occurs in osteoporotic animals, and implant surface properties improve its rate. CONCLUSIONS: Although all modified implants were able to osseointegrate in rats with OVX-induced osteoporosis without pharmacologic intervention, the degree of osseointegration was greater around microstructured/nanostructured/hydrophilic implant surfaces. These results suggest that when appropriate microstructure is present, hydrophilicity has a greater influence on Ti implant osseointegration compared to nanostructures. Moreover, modified implant surfaces can exert their control over the altered bone turnover observed in osteoporotic patients to stimulate functional osseointegration. These results provide critical insight for developing implants with improved osseointegration in patients with metabolic disorders of bone remodeling.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Lotz EM, Cohen DJ, Schwartz Z, et al. Titanium implant surface properties enhance osseointegration in ovariectomy induced osteoporotic rats without pharmacologic intervention. Clin Oral Implants Res. 2020. PMID: 31953969. doi:10.1111/clr.13575

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。